| Beyond Air is a clinical-stage anti-microbial therapeutic company that is developing a single proprietary 160 parts-per-million nitric oxide (NO) formulation and delivery system to treat certain respiratory infections. Co.'s product candidate may be marketed as a combination drug and associated medical device; in that case, any final product would be composed of two distinct components: its proprietary delivery system and a specific gaseous NO drug, each of which may be subject to separate premarket reviews and approvals or clearance by the U.S. Food and Drug Administration. We show 3 historical shares outstanding datapoints in our AITB shares outstanding history coverage, used to compute AITB market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing AITB market cap history over the course of time is important for investors
interested in comparing AITB's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of AITB versus a peer is one thing; comparing
AITB market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like AITB can fluctuate over the course of history.
With this page we aim to empower investors researching AITB by allowing them to research the AITB market cap history.